Di Maio, M., Daniele, G. and Piccirillo, M. (2013) “Impact on health-related quality of life of the addition of bevacizumab to first-line chemotherapy for ovarian cancer:  ”, Cancer Breaking News, 1(1), pp. 33–35. Available at: https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/254 (Accessed: 3 July 2024).